AR053620A1 - Proceso para preparar un 2- desoxi-2,2-difluoro -d-ribofuranosil sulfonato enriquecido en anomero alfa y uso para preparar un nucleosido beta - Google Patents
Proceso para preparar un 2- desoxi-2,2-difluoro -d-ribofuranosil sulfonato enriquecido en anomero alfa y uso para preparar un nucleosido betaInfo
- Publication number
- AR053620A1 AR053620A1 ARP060102350A ARP060102350A AR053620A1 AR 053620 A1 AR053620 A1 AR 053620A1 AR P060102350 A ARP060102350 A AR P060102350A AR P060102350 A ARP060102350 A AR P060102350A AR 053620 A1 AR053620 A1 AR 053620A1
- Authority
- AR
- Argentina
- Prior art keywords
- anomer
- formula
- beta
- mixture
- alpha
- Prior art date
Links
- 150000003833 nucleoside derivatives Chemical class 0.000 title abstract 6
- 239000002777 nucleoside Substances 0.000 title abstract 5
- 238000000034 method Methods 0.000 title abstract 4
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 title abstract 3
- 239000000203 mixture Substances 0.000 abstract 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 7
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 6
- 125000000217 alkyl group Chemical group 0.000 abstract 5
- 125000003118 aryl group Chemical group 0.000 abstract 5
- 125000000547 substituted alkyl group Chemical group 0.000 abstract 5
- 125000003107 substituted aryl group Chemical group 0.000 abstract 5
- 238000010438 heat treatment Methods 0.000 abstract 4
- 238000006243 chemical reaction Methods 0.000 abstract 3
- 239000002904 solvent Substances 0.000 abstract 3
- KBDKOYYFINOWDM-HERZVMAMSA-N (4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)oxolane-2-sulfonic acid Chemical compound OC[C@H]1OC(S(O)(=O)=O)C(F)(F)[C@@H]1O KBDKOYYFINOWDM-HERZVMAMSA-N 0.000 abstract 2
- 238000004519 manufacturing process Methods 0.000 abstract 2
- 239000003960 organic solvent Substances 0.000 abstract 2
- 239000003495 polar organic solvent Substances 0.000 abstract 2
- -1 ribofuranosyl sulfonate Chemical compound 0.000 abstract 2
- 238000003797 solvolysis reaction Methods 0.000 abstract 2
- 239000002246 antineoplastic agent Substances 0.000 abstract 1
- JXLHNMVSKXFWAO-UHFFFAOYSA-N azane;7-fluoro-2,1,3-benzoxadiazole-4-sulfonic acid Chemical class N.OS(=O)(=O)C1=CC=C(F)C2=NON=C12 JXLHNMVSKXFWAO-UHFFFAOYSA-N 0.000 abstract 1
- 239000003153 chemical reaction reagent Substances 0.000 abstract 1
- SDUQYLNIPVEERB-QPPQHZFASA-N gemcitabine Chemical compound O=C1N=C(N)C=CN1[C@H]1C(F)(F)[C@H](O)[C@@H](CO)O1 SDUQYLNIPVEERB-QPPQHZFASA-N 0.000 abstract 1
- 229960005277 gemcitabine Drugs 0.000 abstract 1
- 239000002773 nucleotide Substances 0.000 abstract 1
- 125000003729 nucleotide group Chemical group 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 150000008054 sulfonate salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/048—Pyridine radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/06—Pyrimidine radicals
- C07H19/073—Pyrimidine radicals with 2-deoxyribosyl as the saccharide radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/12—Triazine radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/22—Pteridine radicals
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Un proceso para preparar un 2-desoxi-2,2-difluoro-D-ribofurasonil sulfonato enriquecido en anomero alfa, el cual es util como intermediario en la preparacion de un nucleotido beta, tal como gemcitabina, un agente anti-tumoral. Se calienta un beta-2- desoxi-2,2- difluoro-D-ribofuranosil sulfonato y se convierte en un alfa-2-desoxi-2,2-difluoro-D-ribofuranosil sulfonato en ausencia de una cantidad efectiva de una sal de sulfonato para facilitar la conversion. Además, se puede disolver una mezcla anomérica de un anomero alfa y de un anomero beta de 2-desoxi-2,2-difluoro-D-ribofuranosil sulfonato en una mezcla de agua y un solvente, y calentar para producir un lactol, el que puede además convertirse en un 2-desoxi-2,2-difluoro-D-ribofuranosil sulfonato enriquecido en anomero alfa. Reivindicacion 1: Un proceso para producir un ribofuranosil sulfonato alfa-anomérico de formula (1), a partir de un ribofuranosil sulfonato beta-anomérico de formula (2), caracterizado porque comprende calentar el anomero beta, que está esencialmente libre de solvente, a una temperatura elevada para convertir el anomero beta en el anomero alfa, en ausencia de una cantidad efectiva de una sal de sulfonato para facilitar la conversion del anomero beta en el anomero alfa; donde cada Y se selecciona independientemente a partir de grupos protectores de hidroxilo, y R es un grupo alquilo, alquilo sustituido, arilo o arilo sustituido. Reivindicacion 8: Un proceso para preparar un nucleosido de formula (3), caracterizado porque comprende: a) calentar un anomero beta de formula (2) que está esencialmente libre de solvente a una temperatura elevada para convertir el anomero beta en un anomero alfa de formula (1), en ausencia de una cantidad efectiva de una sal de sulfonato para facilitar la conversion del anomero beta en el anomero alfa; y b) hacer reaccionar el anomero alfa con un derivado de nucleobase para preparar el nucleosido; donde cada Y se selecciona independientemente a partir de grupos protectores de hidroxilo, R es un grupo alquilo, alquilo sustituido, arilo o arilo sustituido; y R' es un nucleobase. Reivindicacion 13: Un proceso para hacer un lactol de formula (4) caracterizado porque comprende los pasos de: a) disolver una mezcla anomérica de formula (5) en una mezcla de un solvente orgánico polar y agua donde cada Y se selecciona independientemente a partir de grupos protectores de hidroxilo, y R es un grupo alquilo, alquilo sustituido, arilo o arilo sustituido; b) calentar la mezcla a una temperatura elevada para producir la reaccion de solvolisis; y c) difluir la mezcla con agua y extraer el lactol con un solvente orgánico miscible con agua. Reivindicacion 22: Un proceso para hacer un nucleosido de formula (3), donde cada Y se selecciona independientemente a partir de grupos protectores de hidroxilo, R' es un nucleobase, caracterizado porque comprende: a) disolver una mezcla anomérica de formula (5) en una mezcla de solvente orgánico polar y agua, donde cada Y se selecciona independientemente a partir de grupos protectores de hidroxilo, y R es un grupo alquilo, alquilo sustituido, arilo o arilo sustituido; b) calentar la mezcla a una temperatura elevada para producir la reaccion de solvolisis; y c) diluir la mezcla con agua y extraer el lactol con un solvente orgánico miscible con agua; d) hacer reaccionar el lactol con un reactivo sulfonante para producir una anomero alfa de formula (1), donde cada Y se selecciona independientemente a partir de grupos protectores de hidroxilo, y R es un grupo alquilo, alquilo sustituido, arilo o arilo sustituido; e) hacer reaccionar el anomero alfa de formula (1) con un derivado de nucleosido para preparar el nucleosido.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US68759305P | 2005-06-03 | 2005-06-03 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR053620A1 true AR053620A1 (es) | 2007-05-09 |
Family
ID=37498755
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP060102350A AR053620A1 (es) | 2005-06-03 | 2006-06-05 | Proceso para preparar un 2- desoxi-2,2-difluoro -d-ribofuranosil sulfonato enriquecido en anomero alfa y uso para preparar un nucleosido beta |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US7572898B2 (es) |
| EP (1) | EP1891087A4 (es) |
| JP (2) | JP5091126B2 (es) |
| KR (1) | KR101171087B1 (es) |
| CN (1) | CN101203525B (es) |
| AR (1) | AR053620A1 (es) |
| AU (1) | AU2006255706B2 (es) |
| BR (1) | BRPI0610950A2 (es) |
| CA (2) | CA2689979C (es) |
| MX (1) | MX2007015174A (es) |
| NZ (1) | NZ563995A (es) |
| TW (1) | TWI322812B (es) |
| WO (1) | WO2006132808A1 (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102140124B (zh) * | 2011-02-26 | 2013-05-15 | 湖南欧亚生物有限公司 | 一种新型的卡培他滨的合成工艺 |
| CN109796506A (zh) * | 2019-01-28 | 2019-05-24 | 江苏八巨药业有限公司 | 一种吉西他滨关键中间体的制备方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4526988A (en) * | 1983-03-10 | 1985-07-02 | Eli Lilly And Company | Difluoro antivirals and intermediate therefor |
| US5256798A (en) * | 1992-06-22 | 1993-10-26 | Eli Lilly And Company | Process for preparing alpha-anomer enriched 2-deoxy-2,2-difluoro-D-ribofuranosyl sulfonates |
| US5606048A (en) * | 1992-06-22 | 1997-02-25 | Eli Lilly And Company | Stereoselective glycosylation process for preparing 2'-Deoxy-2', 2'-difluoronucleosides and 2'-deoxy-2'-fluoronucleosides |
| US5401861A (en) * | 1992-06-22 | 1995-03-28 | Eli Lilly And Company | Low temperature process for preparing alpha-anomer enriched 2-deoxy-2,2-difluoro-D-ribofuranosyl sulfonates |
| UA41261C2 (uk) * | 1992-06-22 | 2001-09-17 | Елі Ліллі Енд Компані | Спосіб одержання збагачених бета-аномером нуклеозидів |
| US5559222A (en) * | 1995-02-03 | 1996-09-24 | Eli Lilly And Company | Preparation of 1-(2'-deoxy-2',2'-difluoro-D-ribo-pentofuranosyl)-cytosine from 2-deoxy-2,2-difluoro-β-D-ribo-pentopyranose |
-
2006
- 2006-05-24 KR KR1020077028260A patent/KR101171087B1/ko not_active IP Right Cessation
- 2006-05-24 MX MX2007015174A patent/MX2007015174A/es active IP Right Grant
- 2006-05-24 WO PCT/US2006/020131 patent/WO2006132808A1/en active Application Filing
- 2006-05-24 EP EP06771094A patent/EP1891087A4/en not_active Withdrawn
- 2006-05-24 NZ NZ563995A patent/NZ563995A/en not_active IP Right Cessation
- 2006-05-24 JP JP2008514697A patent/JP5091126B2/ja not_active Expired - Fee Related
- 2006-05-24 AU AU2006255706A patent/AU2006255706B2/en not_active Ceased
- 2006-05-24 CA CA2689979A patent/CA2689979C/en not_active Expired - Fee Related
- 2006-05-24 US US11/439,664 patent/US7572898B2/en not_active Expired - Fee Related
- 2006-05-24 CN CN2006800195200A patent/CN101203525B/zh not_active Expired - Fee Related
- 2006-05-24 BR BRPI0610950-0A patent/BRPI0610950A2/pt not_active IP Right Cessation
- 2006-05-24 CA CA2610283A patent/CA2610283C/en not_active Expired - Fee Related
- 2006-06-01 TW TW095119351A patent/TWI322812B/zh not_active IP Right Cessation
- 2006-06-05 AR ARP060102350A patent/AR053620A1/es not_active Application Discontinuation
-
2012
- 2012-08-08 JP JP2012176061A patent/JP2012236851A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US7572898B2 (en) | 2009-08-11 |
| EP1891087A1 (en) | 2008-02-27 |
| MX2007015174A (es) | 2008-04-22 |
| US20060276638A1 (en) | 2006-12-07 |
| CA2610283A1 (en) | 2006-12-14 |
| CN101203525A (zh) | 2008-06-18 |
| JP5091126B2 (ja) | 2012-12-05 |
| CA2689979A1 (en) | 2006-12-14 |
| KR20080031172A (ko) | 2008-04-08 |
| EP1891087A4 (en) | 2008-07-30 |
| CA2610283C (en) | 2011-08-30 |
| AU2006255706A1 (en) | 2006-12-14 |
| CN101203525B (zh) | 2012-06-13 |
| TWI322812B (en) | 2010-04-01 |
| KR101171087B1 (ko) | 2012-08-06 |
| CA2689979C (en) | 2013-04-23 |
| JP2008542374A (ja) | 2008-11-27 |
| NZ563995A (en) | 2010-01-29 |
| AU2006255706B2 (en) | 2011-06-23 |
| WO2006132808A1 (en) | 2006-12-14 |
| TW200745150A (en) | 2007-12-16 |
| JP2012236851A (ja) | 2012-12-06 |
| BRPI0610950A2 (pt) | 2010-08-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR101005299B1 (ko) | 바이러스 감염 및 비정상적인 세포 증식의 치료를 위한 변형된 뉴클레오시드 | |
| CL2013003053A1 (es) | Compuesto que comprende un oligonucleotido modificado que consiste en de 10 a 30 nucleósidos unidos y definidos por un grupo de secuencias específicas; composicion que comprende dicho compuesto; uso para tratar enfermedades relacionadas con el virus de la hepatitis b (vhb). | |
| BR0109194A (pt) | Método para preparar claritromicina em cristais da forma ii | |
| BRPI0606324A2 (pt) | derivados de purina agindo como agonistas de receptor de a2a | |
| BR9915636A (pt) | Método para promover secreções cervicais e vaginais | |
| PT2691410T (pt) | Purificação de oligonucleótidos trifosforilados utilizando marcadores de captura | |
| BR112022026056A2 (pt) | Nucleosídeos e nucleotídeos com grupo bloqueador 3? acetal | |
| AR063484A1 (es) | Sal de acido p-toluensulfonico de 5-amino-3-(2'-o-acetil-3'-desoxi-beta-d-ribofuranosil)-3h-tiazol[4, 5-d]pirimidin-2-ona, metodos para la preparacion de la misma y de sus intermediarios de sintesis, una composicion farmaceutica que la comprende y su uso en el tratamiento de infecciones virales y ca | |
| Wolf et al. | Reliable synthesis of various nucleoside diphosphate glycopyranoses | |
| AR053620A1 (es) | Proceso para preparar un 2- desoxi-2,2-difluoro -d-ribofuranosil sulfonato enriquecido en anomero alfa y uso para preparar un nucleosido beta | |
| Sun et al. | 4, 5-Dicyanoimidazole-promoted synthesis of dinucleoside polyphosphates and their analogs | |
| Bristow et al. | 488. Experiments on the synthesis of purine nucleosides. Part XXV. 1: 2: 3: 5-Tetra-acetyl D-arabofuranose and the D-arabofuranosides of theophylline and adenine | |
| Kohn et al. | Synthesis of Aldofuranosyl Nucleosides1 | |
| Zlatev et al. | Deoxygenation of 5-O-benzoyl-1, 2-isopropylidene-3-O-imidazolylthiocarbonyl-α-d-xylofuranose using dimethyl phosphite: an efficient alternate method towards a 3′-deoxynucleoside glycosyl donor | |
| Dukhan et al. | Synthesis of 2′-C-Methyl-4′-Thio Ribonucleosides | |
| Fleet et al. | Methyl 5-O-tert-butyldiphenylsilyl-2-deoxy-D-threo-pentofuranoside; an approach to the syntesis of 3′-substituted-2′, 3′-dideoxynucleosides including 3′-azido-3′-deoxythymidine and of 3′-substituted-2′, 3′-dideoxy-C-nucleosides | |
| CN104072558B (zh) | 具有抗hiv活性的5-取代嘧啶核苷-四氢噻唑杂化体及其制备方法 | |
| Mohamady et al. | Rapid and efficient synthesis of nucleoside polyphosphates and their conjugates using sulfonyl imidazolium salts | |
| Zhang et al. | Synthetic study of 1, 2, 3-tri-O-Acetyl-5-Deoxy-d-Ribofuranose | |
| EP1556396A1 (en) | Method for producing 2-deoxy-l-ribose | |
| CA2743451A1 (en) | Modified nucleosides for the treatment of viral infections and abnormal cellular proliferation | |
| Dabrowski-Tumanski et al. | Synthesis of nucleotide sugars and nucleoside 5'-phosphosulfates by MgCl 2 mediated coupling | |
| Carvalho et al. | Synthesis of 2', N 3-anhydro-nucleosides a new and interesting class of similar rigid nucleosides | |
| Wu | Stereoselectivity in Furanose Glycosylation | |
| Pal et al. | Synthesis of the Trisaccharide Repeating Unit of the Lipopolysaccharide from Moritella viscosa Strain M2-226 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal |